(Q24300823)

negative regulation of plasma lipoprotein oxidation

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

Apolipoprotein M

1 reference

GOA release 2020-03-11

Harry Björkbacka

8

0 references

Peter Plomgaard

Peter Plomgaard

5

0 references

Christoph J Binder

Christoph J Binder

7

0 references

Christina Christoffersen

Christina Christoffersen

3

0 references

Andrew N Hoofnagle

4

Andrew N Hoofnagle

0 references

author name string

Sara Elsøe

1

0 references

Josefin Ahnström

2

0 references

Jay W Heinecke

6

0 references

Björn Dahlbäck

9

0 references

Lars B Nielsen

Multiple molecular recognition properties of the lipocalin protein family

10

0 references

language of work or name

English

0 references

publication date

March 2012

0 references

published in

Atherosclerosis

0 references

volume

221

0 references

issue

1

0 references

page(s)

91-7

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Oxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine induces vascular endothelial superoxide production: implication of NADPH oxidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

The effect of albumin on copper-induced LDL oxidation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

The mechanism of action of antioxidants against lipoprotein peroxidation, evaluation based on kinetic experiments

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

The lipocalin protein family: structural and sequence overview

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Evidence for a role of phospholipid oxidation products in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Lipocalins in drug discovery: from natural ligand-binding proteins to "anticalins".

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

A novel human apolipoprotein (apoM)

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

The signal peptide anchors apolipoprotein M in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Lipoprotein(a) accelerates atherosclerosis in uremic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Isolation and characterization of human apolipoprotein M-containing lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.ATHEROSCLEROSIS.2011.11.031

7 January 2021

10.1016/J.ATHEROSCLEROSIS.2011.11.031

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_5om4yh6u2nfyxdu445ztc6mh4e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5om4yh6u2nfyxdu445ztc6mh4e

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

22204862

1 reference

Consolidated OpenCitations Corpus – April 2017